Live Pharmaceutical Import data of Vietnam imports from china under HS Code 292429 via Port Cchq-ck-cảsài-gòn-kv-i , our Vietnam customs import data reports include date, value, quantity, product description, HS code, port, country, and Vietnam pharmaceutical importers data
| Date |
HS Code |
Product Description |
Origin Country |
Custom Name |
QTY. |
Unit |
Value($) |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-04-03 00:00:00 |
29242930
|
Pharmaceutical raw material: PARACETAMOL BP2022. BATCH NO: 012402077 Manufacturer February 7, 2024 Expiry date February 6, 2028, 100% new. MANUFACTURER: HEBEI JIHENG (GROUP) PHARMACEUTICAL CO.,LTD- China | China | CCHQ CK CảSài Gòn KV I | 17000 | KGM | 56100 | Importer Name |
| 2024-04-04 00:00:00 |
29242990
|
Medicinal Chemical Raw Materials: Methocarbamol, USP 2022, SDK: VD-30501-18, Patient: MCOR-2305005, MCOR-2305010, Manufacturer: 05/2023, HD: 05/2028, Manufacturer: NINGBO SMART PHARMACEUTICAL CO., LTD - CHINA | China | CCHQ CK CảSài Gòn KV I | 1200 | KGM | 18000 | Importer Name |
| 2024-04-12 00:00:00 |
29242990
|
NLDP: PARACETAMOL, Standard: BP2023, Batch no: 012403133, 012403135, 012403137, Mnf: 03/2024, Exp: 03/2028, Manufacturer: Hebei Jiheng Pharmaceutical Co.,Ltd - China (893100224923) | China | CCHQ CK CảSài Gòn KV I | 12000 | KGM | 42000 | Importer Name |
| 2024-04-03 00:00:00 |
29242990
|
Veterinary medicine ingredients: Paracetamol (Batch number: 202403013A; Manufacturer: 03/2024; Expiry date: 02/2028; Manufacturer: Anhui BBCA Likang Pharmaceutical Co., Ltd; QC: 25kg/barrel; 100% new product) | China | CCHQ CK CảSài Gòn KV I | 5000 | KGM | 16500 | Importer Name |
| 2024-04-25 00:00:00 |
29242930
|
Production capacity of modern medicine PARACETAMOL (MICRONIZED POWDER form);TCCL:BP2022, Manufacturer:ANQIU LU`AN PHARMACEUTICAL CO.-CHINA;Batch:2450503,SX:March 16, 2024,HD:March 16, 2028;CB:VD -32727-19 | China | CCHQ CK CảSài Gòn KV I | 200 | KGM | 1700 | Importer Name |
| 2024-04-04 00:00:00 |
29242990
|
Pharmaceutical Chemical Raw Materials for Medicine: Paracetamol, BP 2023, Patient: 2450484, SDK: VD-34233-20, Manufacturer: March 2024, HD: March 2028, Manufacturer: ANQIU LU AN PHARMACEUTICAL CO., LTD - CHINA | China | CCHQ CK CảSài Gòn KV I | 3125 | KGM | 10906.25 | Importer Name |
| 2024-04-05 00:00:00 |
29242990
|
Pharmaceutical raw materials: Paracetamol; USP43 ; Batch No:2410216; Production: February 28, 2024, Expiry date: February 28, 2028; batch no: 2450388; Production: February 29, 2024; Expiration: February 29, 2024; Anqiu Luan Pharmaceutical Co., Ltd; Regist | China | CCHQ CK CảSài Gòn KV I | 11000 | KGM | 39270 | Importer Name |
| 2024-04-11 00:00:00 |
29242930
|
Raw material for drug production has number: Example-23105-15 :PARACETAMOL BP2023 Lot: 0124012(64;69;71;72); 0124030(35;37)-Manufacturer:01;03/2024- HD:01;03/2028-Manufacturer:HEBEI JIHENG PHARMACEUTICAL COMPANY LTD | China | CCHQ CK CảSài Gòn KV I | 24000 | KGM | 96000 | Importer Name |
2024-04-03 00:00:00
Pharmaceutical raw material: PARACETAMOL BP2022. BATCH NO: 012402077 Manufacturer February 7, 2024 Expiry date February 6, 2028, 100% new. MANUFACTURER: HEBEI JIHENG (GROUP) PHARMACEUTICAL CO.,LTD- China
17000
KGM
56100
2024-04-04 00:00:00
Medicinal Chemical Raw Materials: Methocarbamol, USP 2022, SDK: VD-30501-18, Patient: MCOR-2305005, MCOR-2305010, Manufacturer: 05/2023, HD: 05/2028, Manufacturer: NINGBO SMART PHARMACEUTICAL CO., LTD - CHINA
1200
KGM
18000
2024-04-12 00:00:00
NLDP: PARACETAMOL, Standard: BP2023, Batch no: 012403133, 012403135, 012403137, Mnf: 03/2024, Exp: 03/2028, Manufacturer: Hebei Jiheng Pharmaceutical Co.,Ltd - China (893100224923)
12000
KGM
42000
2024-04-03 00:00:00
Veterinary medicine ingredients: Paracetamol (Batch number: 202403013A; Manufacturer: 03/2024; Expiry date: 02/2028; Manufacturer: Anhui BBCA Likang Pharmaceutical Co., Ltd; QC: 25kg/barrel; 100% new product)
5000
KGM
16500
2024-04-25 00:00:00
Production capacity of modern medicine PARACETAMOL (MICRONIZED POWDER form);TCCL:BP2022, Manufacturer:ANQIU LU`AN PHARMACEUTICAL CO.-CHINA;Batch:2450503,SX:March 16, 2024,HD:March 16, 2028;CB:VD -32727-19
200
KGM
1700
2024-04-04 00:00:00
Pharmaceutical Chemical Raw Materials for Medicine: Paracetamol, BP 2023, Patient: 2450484, SDK: VD-34233-20, Manufacturer: March 2024, HD: March 2028, Manufacturer: ANQIU LU AN PHARMACEUTICAL CO., LTD - CHINA
3125
KGM
10906.25
2024-04-05 00:00:00
Pharmaceutical raw materials: Paracetamol; USP43 ; Batch No:2410216; Production: February 28, 2024, Expiry date: February 28, 2028; batch no: 2450388; Production: February 29, 2024; Expiration: February 29, 2024; Anqiu Luan Pharmaceutical Co., Ltd; Regist
11000
KGM
39270
2024-04-11 00:00:00
Raw material for drug production has number: Example-23105-15 :PARACETAMOL BP2023 Lot: 0124012(64;69;71;72); 0124030(35;37)-Manufacturer:01;03/2024- HD:01;03/2028-Manufacturer:HEBEI JIHENG PHARMACEUTICAL COMPANY LTD
24000
KGM
96000
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 292429 for Vietnam pharmaceutical imports from Thailand via Port Cchq-ck-cảsài-gòn-kv-i.
Port Cchq-ck-cảsài-gòn-kv-i typically refers to a port that is used for handling and forwarding shipments into Vietnam, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharmaceutical products, enabling better decision-making for trade and market expansion for Vietnam pharmaceutical imports from china under HS code 292429 via Port Cchq-ck-cảsài-gòn-kv-i.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharmaceutical market.
